BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 20851657)

  • 21. Rheumatoid arthritis: new monoclonal antibodies.
    Serio I; Tovoli F
    Drugs Today (Barc); 2018 Mar; 54(3):219-230. PubMed ID: 29771256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Onset of systemic lupus erythematosus after conversion of infliximab to adalimumab treatment in rheumatoid arthritis with a pre-existing anti-dsDNA antibody level.
    van Rijthoven AW; Bijlsma JW; Canninga-van Dijk M; Derksen RH; van Roon JA
    Rheumatology (Oxford); 2006 Oct; 45(10):1317-9. PubMed ID: 16844698
    [No Abstract]   [Full Text] [Related]  

  • 23. A clinical perspective of rheumatoid arthritis.
    Scherer HU; Burmester GR
    Eur J Immunol; 2009 Aug; 39(8):2044-8. PubMed ID: 19672900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blockade of interleukin 6 signaling induces marked neutropenia in patients with rheumatoid arthritis.
    Nakamura I; Omata Y; Naito M; Ito K
    J Rheumatol; 2009 Feb; 36(2):459-60. PubMed ID: 19208585
    [No Abstract]   [Full Text] [Related]  

  • 25. Leukoencephalopathy with cognitive impairment following tocilizumab for the treatment of rheumatoid arthritis (RA).
    Kobayashi K; Okamoto Y; Inoue H; Usui T; Ihara M; Kawamata J; Miki Y; Mimori T; Tomimoto H; Takahashi R
    Intern Med; 2009; 48(15):1307-9. PubMed ID: 19652436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful treatment with humanised anti-interleukin 6 receptor antibody for multidrug-refractory and anti-tumour necrosis factor-resistant systemic rheumatoid vasculitis.
    Sumida K; Ubara Y; Takemoto F; Takaichi K
    Clin Exp Rheumatol; 2011; 29(1 Suppl 64):S133. PubMed ID: 21385558
    [No Abstract]   [Full Text] [Related]  

  • 27. [Brachial plexitis and myelitis and herpes-zoster lumbar plexus disorder in patient treated with infliximab].
    Arias M; Arias-Rivas S; Dapena D; Mera A
    Neurologia; 2005 Sep; 20(7):374-6. PubMed ID: 16163582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association Between Medications and Herpes Zoster in Japanese Patients with Rheumatoid Arthritis: A 5-year Prospective Cohort Study.
    Harada S; Sakai R; Hirano F; Miyasaka N; Harigai M;
    J Rheumatol; 2017 Jul; 44(7):988-995. PubMed ID: 28412701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Severe herpes zoster after infliximab infusion.
    Kinder A; Stephens S; Mortimer N; Sheldon P
    Postgrad Med J; 2004 Jan; 80(939):26. PubMed ID: 14760175
    [No Abstract]   [Full Text] [Related]  

  • 30. Herp zoster at the site of infliximab infusion: case report.
    Cruz MJ; Baudrier T; Ferreira O; Azevedo F
    Cutan Ocul Toxicol; 2011 Sep; 30(3):236-8. PubMed ID: 21299443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Profile of sarilumab and its potential in the treatment of rheumatoid arthritis.
    Raimondo MG; Biggioggero M; Crotti C; Becciolini A; Favalli EG
    Drug Des Devel Ther; 2017; 11():1593-1603. PubMed ID: 28579757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-interleukin-6 therapy in rheumatoid arthritis.
    Woodrick R; Ruderman EM
    Bull NYU Hosp Jt Dis; 2010; 68(3):211-7. PubMed ID: 20969554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ramsay Hunt syndrome associated with tocilizumab therapy in rheumatoid arthritis: a case report.
    Mimata Y; Akasaka T; Nakano R; Murata T; Kawashima M; Shimamura T
    Int J Rheum Dis; 2013 Jun; 16(3):367-8. PubMed ID: 23981764
    [No Abstract]   [Full Text] [Related]  

  • 34. Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy.
    Lan JL; Chen YM; Hsieh TY; Chen YH; Hsieh CW; Chen DY; Yang SS
    Ann Rheum Dis; 2011 Oct; 70(10):1719-25. PubMed ID: 21719446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Rheumatoid polyarthritis: a new treatment].
    Perspect Infirm; 2010; 7(5):46-7. PubMed ID: 21744636
    [No Abstract]   [Full Text] [Related]  

  • 36. Anti-TNF-alpha therapies: they are all the same (aren't they?).
    Mpofu S; Fatima F; Moots RJ
    Rheumatology (Oxford); 2005 Mar; 44(3):271-3. PubMed ID: 15561736
    [No Abstract]   [Full Text] [Related]  

  • 37. Targeting IL-6 or IL-6 Receptor in Rheumatoid Arthritis: What's the Difference?
    Avci AB; Feist E; Burmester GR
    BioDrugs; 2018 Dec; 32(6):531-546. PubMed ID: 30488231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interlukin-6 receptor inhibitor tocilizumab: a new treatment option in rheumatoid arthritis?
    Johnson J; Wang MY
    Neurosurgery; 2008 Aug; 63(2):N8. PubMed ID: 18797345
    [No Abstract]   [Full Text] [Related]  

  • 39. Ophthalmic herpes zoster infection in patients with rheumatoid arthritis who were treated with tocilizumab.
    Roux C; Breuil V; Albert C; Allam V; Grisot C; Chami H; Dasilva V; Euller-Ziegler L
    J Rheumatol; 2011 Feb; 38(2):399. PubMed ID: 21285184
    [No Abstract]   [Full Text] [Related]  

  • 40. [Adverse effects of biologic agents in treatment of rheumatoid arthritis--prevention of tuberculosis].
    Tomono K; Hashimoto S
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():573-8. PubMed ID: 15799420
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.